In samples collected from the blood of breast cancer patients, the expression of Sirt2 was lower in comparison to healthy individuals, and Sirt2-deficient mice demonstrated decreased TEM cells with increased naïve T-cell levels [106]. The gene discussed is SIRT2; the disease is breast carcinoma.